In	O
situ	O
alkylation	O
of	O
cysteine	O
residues	O
in	O
a	O
hydrophobic	O
membrane	B-Cellular_component
protein	O
immobilized	O
on	O
polyvinylidene	O
difluoride	O
membranes	O
by	O
electroblotting	O
prior	O
to	O
microsequence	O
and	O
amino	O
acid	O
analysis	O
.	O

For	O
identification	O
of	O
cysteine	O
residues	O
on	O
microsequence	O
analysis	O
it	O
is	O
crucial	O
to	O
derivatize	O
the	O
sulfhydryl	O
groups	O
.	O

This	O
reaction	O
requires	O
a	O
desalting	O
step	O
which	O
often	O
represents	O
a	O
major	O
obstacle	O
,	O
especially	O
if	O
the	O
sample	O
consists	O
of	O
limited	O
amounts	O
of	O
a	O
hydrophobic	O
membrane	B-Cellular_component
protein	O
.	O

An	O
alkylation	O
procedure	O
is	O
described	O
,	O
allowing	O
efficient	O
derivatization	O
(	O
greater	O
than	O
90	O
%	O
)	O
of	O
cysteines	O
and	O
cystines	O
even	O
in	O
low	O
microgram	O
quantities	O
,	O
as	O
revealed	O
by	O
test	O
analyses	O
with	O
lysozyme	O
and	O
a	O
hydrophobic	O
membrane	B-Cellular_component
protein	O
.	O

The	O
modified	O
protein	O
is	O
recovered	O
in	O
high	O
yields	O
in	O
a	O
form	O
suitable	O
for	O
both	O
microsequence	O
analysis	O
and	O
amino	O
acid	O
analysis	O
.	O

The	O
method	O
involves	O
electrophoretic	O
desalting	O
by	O
miniaturized	O
Tricine	O
-	O
sodium	O
dodecyl	O
sulfate	O
-	O
polyacrylamide	O
gel	O
electrophoresis	O
and	O
in	O
situ	O
alkylation	O
after	O
electro	O
-	O
transfer	O
onto	O
polyvinylidene	O
difluoride	O
membranes	O
.	O

Precautions	O
against	O
NH2	O
-	O
terminal	O
blocking	O
during	O
sample	O
preparations	O
are	O
provided	O
.	O

The	O
general	O
applicability	O
of	O
the	O
method	O
is	O
illustrated	O
by	O
the	O
structural	O
characterization	O
of	O
the	O
low	O
abundance	O
membrane	B-Cellular_component
receptor	O
for	O
human	O
urokinase	O
plasminogen	O
activator	O
.	O

